Figure 1.

CRLX101 is a novel nanoparticle drug conjugate (NDC) that contains a cyclodextrin-containing polymer (CDP) conjugated to camptothecin (CPT) that self assembles into 20 to 40 nm diameter nanoparticles. Adapted from Clark et al. (9).